Dergiler / Veterinary Sciences and Practices / 2015 / Cilt: 10 - Sayı: 2

Exposure to Terbinafine is Associated with Abnormal Skin Development in The Newborn Rats

The Relationship Between the Prenatal Exposure to Terbinafine and Abnormal Skin Development in the Newborn Rats

Sayfa
1–1
Yayın Tarihi
2015-10-20
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In conclusion, during pregnancy, terbinafine application time and dose-dependent can cause abnormalities of the skin and growth retardation in newborn rats.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This study was designed to investigate teratogenic effects of prenatal terbinafine exposure in newborn rats in terms of macroscopic anomalies, anthropometric scales and abnormalities in the skin development.
📊
Temel Bulgular & Veri:Female Wistar-Albino rats (250–300 g) were randomly divided into control group (physiological saline, during pregnancy; n=6), group A (terbinafine treatment, 20 mg/kg/day, for 21 days; n=6), group B (terbinafine treatment, 20 mg/kg/day, for 51 days; n=6) and group C (terbinafine treatment, 60 mg/kg/day, for 21 days; n=6).
💡
Sonuç & Katkı:In conclusion, during pregnancy, terbinafine application time and dose-dependent can cause abnormalities of the skin and growth retardation in newborn rats.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Deri · Sıçan · Teratojenik

Özet

This study was designed to investigate teratogenic effects of prenatal terbinafine exposure in newborn rats in terms of macroscopic anomalies, anthropometric scales and abnormalities in the skin development. Female Wistar-Albino rats (250–300 g) were randomly divided into control group (physiological saline, during pregnancy; n=6), group A (terbinafine treatment, 20 mg/kg/day, for 21 days; n=6), group B (terbinafine treatment, 20 mg/kg/day, for 51 days; n=6) and group C (terbinafine treatment, 60 mg/kg/day, for 21 days; n=6). After birth, Five rat pups from each experimental group were sacrificed by intracardiac infusion of 10% formalin. Skin biopsies were performed from the abdominal region and prepared for light microscopic analysis. Hyperkeratosis, epidermal atrophy, disordered epidermal cell lineage were demonstrated in all terbinafine doses with increase in severity at higher doses. Damage to hair follicles was observed in group B and C. In conclusion, during pregnancy, terbinafine application time and dose-dependent can cause abnormalities of the skin and growth retardation in newborn rats.

Abstract

This study was designed to investigate teratogenic effects of prenatal terbinafine exposure in newborn rats in terms of macroscopic anomalies, anthropometric scales and abnormalities in the skin development. Female Wistar-Albino rats (250–300 g) were randomly divided into control group (physiological saline, during pregnancy; n=6), group A (terbinafine treatment, 20 mg/kg/day, for 21 days; n=6), group B (terbinafine treatment, 20 mg/kg/day, for 51 days; n=6) and group C (terbinafine treatment, 60 mg/kg/day, for 21 days; n=6). After birth, Five rat pups from each experimental group were sacrificed by intracardiac infusion of 10% formalin. Skin biopsies were performed from the abdominal region and prepared for light microscopic analysis. Hyperkeratosis, epidermal atrophy, disordered epidermal cell lineage were demonstrated in all terbinafine doses with increase in severity at higher doses. Damage to hair follicles was observed in group B and C. In conclusion, during pregnancy, terbinafine application time and dose-dependent can cause abnormalities of the skin and growth retardation in newborn rats.

🔖

Bu Makaleye Atıf Yap

CAN, İ., İNALÖZ, H. S., İNALÖZ, S. S., KIRTAK, N., ERALP, A., GÜVENDİ, G. F. (2015). Exposure to Terbinafine is Associated with Abnormal Skin Development in The Newborn Rats. Veterinary Sciences and Practices, Cilt: 10 - Sayı: 2, 1–1. https://ajindex.com/articles/825802

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Bahadir S., Inaloz HS., Alpay K., Agaoglu C., Cimsit G., Parlat P., Tak H., 2000. Continuous terbinafine or pulse itraconazole: A comparative study on onychomycosis. J. Eur. Acad. Dermatol. Venereol., 14, 422-423.
  2. Bar-Oz B., Moretti ME., Mareels G., VanTittelboom T., Koren G., 1999. Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet, 13, 1700-1701.
  3. Bar-Oz B., Moretti ME., Bishais R., Mareels G., VanTittelboom T., Verspeelt J., Koren G., 2000. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am. J. Obstet. Gynecol., 183, 617-620. Begg EJ., 2008. Prescribing in pregnancy and lactation. Brit. J. Clin. Pharmaco., 65(5), 627-628.
  4. Contini C., Colombo D., Cultrera R., Prini E., Sechi T., Angelici E., Canipari R., 1996. Employment of terbinafine against pneumocystis carinii infection in rat models. Br. J. Dermatol., 46, 30-32.
  5. Czeizel AE., Metneki J., Kazy Z., Puho E., 2004. A population-based case-control study of oral griseofulvin treatment during pregnancy. Acta. Obstet. Gyn. Scan., 83(9), 827-831.
  6. De Santis M., Di Gianantonio E., Cesari E., Ambrosini G., Straface G., Clementi M., 2009. First-trimester itraconazole exposure and pregnancy outcome a prospective cohort study of women contacting teratology information services in Italy. Drug Saf., 32(3), 239-244.
  7. DeVane L., Goetzl LM., Ramamoorthy S., 2011. Exposing fetal drug exposure. Clin. Pharmacol. Ther., 89(6), 786-788.
  8. Deveci E., Inaloz SS., Inaloz HS., 1998. Teratogenic effects of cadmium on rat skin. Acta. Dermatologica-Kyoto., 93(2), 155-159.
  9. Fletcher H., Williams NP., Nicholson A., Rainford L., Phillip H., East-Innis A., 2000, Systemic phaeohyphomycosis in pregnancy and the puerperium. West. Indian. Med. J., 49, 79-82.
  10. Gupta AK., Shear NH., 1997. Terbinafine: an update. J. Am. Acad. Dermatol., 37(6), 979-988.
  11. Inaloz HS., Ketani MA., Inaloz SS., Yilmaz F., Ketani S., 2000a. The effects of sialoadenectomy and flutamide on skin development. Intl. J. Clin. Exp. Obst. Gynecol., 26, 231-234.
  12. Inaloz HS., Inaloz SS., Deveci E., Eralp A., 2000b. Teratogenic effects of nicotine on rat skin. Intl. J. Clin. Exp. Obst. Gynecol., 26, 241-243.
  13. Inaloz HS., Sari I., Inaloz SS., Bayhan G., Unal B., Yayla M., Eralp A., Yuncu M., 2000c. The effects of unilateral uterine artery ligation on skin development. Intl. J. Clin. Exp. Obst. Gynecol., 26, 218-220.
  14. Katic J., Fucic A., Gamulin M., 2010. Prenatal, early life, and childhood exposure to genotoxicants in